Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunoco
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
https://www.thelancet.com/journals/l...065-1/fulltext Here's Yet Another Reason to Stay on Top of Your COVID Vaccine Boosters https://www.sciencealert.com/heres-y...ccine-boosters "...If the effects don't fade too rapidly, new data suggests regular COVID-19 vaccinations could strengthen our immune systems against future variants and even related viruses. This is on top of the proven protection they already provide against current infections..." |
All times are GMT -7. The time now is 09:37 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021